Related Experiment Videos
Properties of the infectious bursal agent of chicken (IBA)
Medical Microbiology and Immunology
|January 1, 1972
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Management of multiresistant bacteria in urology].
Der Urologe. Ausg. A·2017
Management of Surfing Injuries: A Plastic Surgeon's Viewpoint.
The Physician and sportsmedicine·2016
Enteropathogenic Escherichia coli in Psittaciformes.
Avian pathology : journal of the W.V.P.A·2016
The urban pigeon (Columba livia, Forma urbana) - A biomonitor for the lead burden of the environment.
Environmental monitoring and assessment·2013
[Asymptomatic Renal Stones: Do they really Exist?].
Aktuelle Urologie·2011
A novel TWO-STEP renaturation procedure for efficient production of recombinant BMP-2.
Protein expression and purification·2010
Interferon-γ-response to mycobacterial glycopeptidolipids in patients with pulmonary non-tuberculous mycobacterial infection.
Medical microbiology and immunology·2026
PPAR-γ participates in macrophage polarization induced by Pentatrichomonas hominis.
Medical microbiology and immunology·2026
Pneumococcal vaccine serotype-specific antibody levels among PCV-unvaccinated children in Karnataka, India.
Medical microbiology and immunology·2026
Identification of a novel conserved B-cell epitope in the glycoprotein of rabies virus.
Medical microbiology and immunology·2026
Epstein-Barr virus serological profiles and atypical patterns in a large tertiary-care cohort: a retrospective study of 11,503 patients.
Medical microbiology and immunology·2026
Single-cell profiling reveals IFI44L as a central regulator of immune dysregulation in high HIV viral load.
Medical microbiology and immunology·2026
Tripartite Interplay of Epithelial, Immune, and Microbiota Dysregulation in Crohn's Disease: Mechanisms and Translational Strategies.
Immunity, inflammation and disease·2026
Immune checkpoint inhibition enhances memory T-cell responses to CEF(T), SARS-CoV-2 spike proteins and ChAdOx1 nCoV-19.
Human vaccines & immunotherapeutics·2026